» Articles » PMID: 22784457

The Roles of Genetic and Environmental Factors on Risk of Cervical Cancer: a Review of Classical Twin Studies

Overview
Specialty Genetics
Date 2012 Jul 13
PMID 22784457
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer is the third most common cancer in women worldwide. Persistent infection with an oncogenic human papillomavirus (HPV) is necessary, but not sufficient, for its development. Over many years, only a small proportion of women with chronic HPV infection progress to develop disease. The role of host genes and environmental factors in the pathogenesis of, or predisposition to, cervical cancer is still unclear. We conducted a systematic review of published literature in MEDLINE-PubMed to identify studies of cervical cancer susceptibility that used a twin study design. We used standard MeSH terms (controlled vocabulary) as well as specific free-text terms and combinations of terms related to cervical cancer, with no restriction on publication date. We performed a full text review to ensure the identified articles met our inclusion criteria and, if so, extracted information on demographics, sample size, study definitions, and key statistical findings. Of the 285 articles identified, three utilized a classical twin design and reported results specific to cervical cancer. The studies were based on cancer registry data from Scandinavia, with sample sizes ranging from 312 to 710 twin pairs. The findings from one study were consistent with a genetic mechanism for the causation of carcinoma in situ. Future research studies using the strength of the classic twin design, together with incorporation of HPV DNA status, are indicated to determine whether there is a potential role for genetic factors in the development of cervical cancer or high-grade cervical dysplasia from chronic oncogenic HPV infection.

Citing Articles

Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.

Dehghani A, Khajepour F, Dehghani M, Razmara E, Zangouey M, Fekri Soofi Abadi M BMC Infect Dis. 2024; 24(1):182.

PMID: 38342922 PMC: 10860252. DOI: 10.1186/s12879-023-08942-1.


Unpacking the Lay Epidemiology of Cervical Cancer: A Focus Group Study on the Perceptions of Cervical Cancer and Its Prevention among Women Late for Screening in Norway.

Aasbo G, Hansen B, Waller J, Nygard M, Solbraekke K Healthcare (Basel). 2023; 11(10).

PMID: 37239727 PMC: 10218218. DOI: 10.3390/healthcare11101441.


Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women.

Morales C, Jimenez N, Herbst-Kralovetz M, Lee N Med Sci (Basel). 2022; 10(3).

PMID: 36135837 PMC: 9503187. DOI: 10.3390/medsci10030052.


Association of the Polymorphism and Cervical Cancer Risk: A Meta-Analysis.

Diakite B, Kassogue Y, Maiga M, Dolo G, Kassogue O, Musa J Genet Res (Camb). 2022; 2022:2319161.

PMID: 35919032 PMC: 9296312. DOI: 10.1155/2022/2319161.


Antiproliferative and apoptotic potential of Glycyrrhizin against HPV16+ Caski cervical cancer cells: A plausible association with downreguation of HPV E6 and E7 oncogenes and Notch signaling pathway.

Ahmad A, Tiwari R, Mishra P, Alkhathami A, Almeleebia T, Alshahrani M Saudi J Biol Sci. 2022; 29(5):3264-3275.

PMID: 35844403 PMC: 9280173. DOI: 10.1016/j.sjbs.2022.01.054.